MedTrace Logo

Vetal Laban Intervention Trial Assessing Bowel Symptoms

NCT01887483 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2015-12-22

No results posted yet for this study

Summary

A two month intervention trial assessing the effect of Vetal Laban containing L. acidophilus on enhancing functional bowel wellbeing among subjects with irritable bowel syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Vetal Laban active

Dairy product with probiotic

DIETARY_SUPPLEMENT

Placebo

Dairy product without probiotic

Sponsors & Collaborators

  • Almarai

    collaborator UNKNOWN

  • Clinart International

    collaborator INDUSTRY

  • Danisco

    lead INDUSTRY

Principal Investigators

  • Abdullah Aljahdali, MD · King Abdulaziz National Guard Hospital, Riyadh, Kingdom of Saudi Arabia

  • Arthur C Ouwehand, PhD · Danisco Sweeteners Ltd.

  • Anna H Lyra, PhD · Danisco Sweeteners Ltd.

  • Suzanne Alodaib, MSc · Almarai Company, Saudi Arabia

  • Abed Allehibi, Dr · King Fahd Medical City

  • Othman Al-Harbi, Dr · King Khalid University Hospital

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01887483 on ClinicalTrials.gov